Australia & Canada — Health Canada

Australia: Australia is a key international market where MedMira is initiating regulatory approval for its Canada — Health Canada-approved products under a Mutual Recognition Agreement, aiming to accelerate market entry and expand its international presence.

Canada — Health Canada: Canada — Health Canada is the regulatory body providing initial feedback to MedMira regarding the approval process for its Multiplo Complete Syphilis Antibody Test.

Australia: Australia is the recipient country for Optimi Health's psilocybin capsules, providing a regulated market for the treatment of treatment-resistant depression and setting a model for psychedelic medicine use.

Canada — Health Canada: Canada — Health Canada issued the Drug Establishment Licence for Optimi Health's facility and the export authorization for the psilocybin shipment to Australia, regulating the production and export of these controlled substances.